VABREPTA Trademark

Trademark Overview


On Wednesday, April 17, 2019, a trademark application was filed for VABREPTA with the United States Patent and Trademark Office. The USPTO has given the VABREPTA trademark a serial number of 88389799. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Wednesday, August 21, 2019. This trademark is owned by Glaxo Group Limited. The VABREPTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
vabrepta

General Information


Serial Number88389799
Word MarkVABREPTA
Filing DateWednesday, April 17, 2019
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateWednesday, August 21, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 23, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateWednesday, August 21, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Trademark Events


Event DateEvent Description
Wednesday, August 21, 2019ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Wednesday, August 21, 2019ABANDONMENT - AFTER PUBLICATION
Friday, August 16, 2019TEAS EXPRESS ABANDONMENT RECEIVED
Friday, August 16, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 16, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 15, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 15, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 23, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, June 15, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 10, 2019ASSIGNED TO EXAMINER
Friday, May 3, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, April 20, 2019NEW APPLICATION ENTERED IN TRAM